Literature DB >> 20492994

Immunological evidence for existence of two subforms of soluble glutamic oxaloacetic transminase (sGOT) in human and rat brain.

W E Heydorn1, G Joseph Creed, H Wada, D M Jacobowitz.   

Abstract

Using a sensitive and specific antiserum, the existence of two subforms of soluble glutamic oxaloacetic transaminase in both rat and human brain has been demonstrated. In the rat, the two proteins each have a molecular mass of 47,000 daltons. The more abundant basic protein has an isoelectric point of 5.9 while the sparsely staining more acidic protein has an isoelectric point of 5.8. In the human the two proteins visualized each have a molecular mass of 43,000 daltons. The more abundant basic protein has an isoelectric point of 5.7 while the sparsely staining more acidic protein has an isoelectric point of 5.6. In both rat and human, it seems reasonable to conclude that the abundant basic protein that reacts with the antiserum is the ? subform of the enzyme, while the sparsely staining more acidic protein is the ? subform of the enzyme. These results are of interest for a number of reasons. First, they establish the existence of at least two subforms of soluble glutamic oxaloacetic transaminase in both rat and human brain. Secondly, they show that this enzyme is a major protein visible on two-dimension gels of rat and human brain and that this enzyme is widely distributed throughout the central nervous system. Finally, they positively identify two more proteins visible on two-dimension gels generated using rat or human brain tissue.

Entities:  

Year:  1985        PMID: 20492994     DOI: 10.1016/0197-0186(85)90039-7

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  Professional biographical sketch.

Authors:  David M Jacobowitz
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Fourteen genetically variant proteins of mouse brain: discovery of two new variants and chromosomal mapping of four loci.

Authors:  D Goldman; H J Pikus
Journal:  Biochem Genet       Date:  1986-04       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.